Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing.

Slides:



Advertisements
Similar presentations
Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard.
Advertisements

Study design: a randomized placebo- controlled crossover trial of 2 periods of 4 weeks Nicole A.J. van der Linde, et al. Hypertension 2006;47;
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Angiotensin II type 1 receptor antagonist decreases.
From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):
George E. Yanulis, MEng, MS, Pascal Lim, MD, Ali Ahmad, MD, Zoran B
Copyright © 2015 American Medical Association. All rights reserved.
All-cause mortality by treatment group
by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
by Adam J. Singer, Robert H
Left Ventricular Dysfunction With Pulmonary Hypertension
Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota by Carolyn.
Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction:
Attenuation of the “White-Coat Effect” by Antihypertensive Treatment and Regression of Target Organ Damage by Gianfranco Parati, Luisa Ulian, Lorena Sampieri,
Circ Cardiovasc Qual Outcomes
Atrial Fibrillation and Mortality in Heart FailureClinical Perspective
Right Ventricular Failure in Idiopathic Pulmonary Arterial Hypertension Is Associated With Inefficient Myocardial Oxygen UtilizationClinical Perspective.
CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure by Benjamin W. Van Tassell, Justin Canada, Salvatore Carbone, Cory Trankle, Leo.
Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated CardiomyopathyClinical Perspective by Diane Fatkin, Thomas.
Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart FailureCLINICAL PERSPECTIVE by.
by Katie Ayers, Loretta M. Byrne, Anthony DeMatteo, and Nancy J. Brown
Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart FailureCLINICAL.
Diets Containing Pistachios Reduce Systolic Blood Pressure and Peripheral Vascular Responses to Stress in Adults With DyslipidemiaNovelty and Significance.
Age-Related Differences in Phosphodiesterase Activity and Effects of Chronic Phosphodiesterase Inhibition in Idiopathic Dilated CardiomyopathyCLINICAL.
Blood Pressure and Adverse Events During Continuous Flow Left Ventricular Assist Device SupportCLINICAL PERSPECTIVE by Omar Saeed, Rita Jermyn, Faraj Kargoli,
Circ Cardiovasc Interv
Effect of intervention on diastolic function.
by Parag C. Patel, Colby R. Ayers, Sabina A
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.
Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,
Optimal Pacing for Right Ventricular and Biventricular Devices
by Peter J. Schwartz, Maria Teresa La Rovere, Gaetano M
by Alexander Leaf, Christine M
Oana Dickinson et al. JACEP 2016;2:
The pathophysiology of myocardial infarction-induced heart failure
Volume 10, Issue 10, Pages (October 2013)
A 47-Year-Old Man With Recurrent Unilateral Pleural Effusion
Volume 10, Issue 10, Pages (October 2013)
George E. Yanulis, MEng, MS, Pascal Lim, MD, Ali Ahmad, MD, Zoran B
Normal ranges by corrected gestational age at scan for bFFE assessment of left ventricular output (A), end-diastolic volume (B), end-systolic volume (C)
Cardiac Vagal Stimulation Eliminates Detrimental Tachycardia Effects of Dobutamine Used for Inotropic Support  Youhua Zhang, MD, PhD, Todor N. Mazgalev,
Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106
Chapter 28 Nutrition, Lifestyle, and Hypertension
Juan A. Crestanello, MD, Richard C. Daly, MD 
Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction:
The effect of GOODCOLL versus POORCOLL on LVEF, LVEDV and scar at 4 months. The effect of GOODCOLL versus POORCOLL on LVEF, LVEDV and scar at 4 months.
Ao, aorta; CEOA, corrected effective orifice area; CFD, color-flow Doppler; CW, continuous-wave; DBP, diastolic blood pressure; LV EDP, left ventricular.
Influence of possible intermediary variables on PR interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.
Impact of physiologic pacing versus right ventricular pacing among patients with left ventricular ejection fraction greater than 35%: A systematic review.
Connie W. Tsao et al. JCHF 2016;4:
William T. Abraham et al. JCHF 2015;3:
Bar chart of cardiac volumes and EF in the healthy individuals, HCM LVH− patients and HCM LVH+ patients. Blue bars show the indexed diastolic volumes (EDVI.
Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial  Michael A. Acker, MD,
Nat. Rev. Cardiol. doi: /nrcardio
Romain Gallet et al. BTS 2016;1:14-28
Time course of changes in left ventricular ejection fraction (LVEF) and left ventricular diastolic dimension (LVDd) in 13 patients with the development.
Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.
Relationship between the change in left ventricular ejection fraction (ΔLVEF) and change in left ventricular diastolic dimension (ΔLVDd) at 4 years at.
J. Craig Hartman et al. BTS 2018;3:
Influence of possible intermediary variables on QTc interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.
Himanshu J. Patel, MDa, Edward B. Lankford, MD, PhDb, David J
Connie W. Tsao et al. JCHF 2016;4:
Rick A. Nishimura et al. JACC 2014;63:e57-e185
Average left ventricular ejection fraction (LVEF) values during the 1 year of observation in patients with preserved systolic function (LVEF >40%) and.
Unadjusted means by smoking status
Rick A. Nishimura et al. JACC 2017;70:
Histograms of LVESVI, LVEDVI, LVMI, and 3D LVEF Tabulations of frequencies of left ventricular end-systolic volume (A), end-diastolic volume (B), mass.
Philippe Pibarot et al. JIMG 2015;8:
The distribution of systolic blood pressure (SBP) in male (blue) and female (red) athletes with mean values (SD) presented for each sex (panel A). The.
Presentation transcript:

Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing ModelCLINICAL PERSPECTIVE by Youhua Zhang, Zoran B. Popović, Steve Bibevski, Itaf Fakhry, Domenic A. Sica, David R. Van Wagoner, and Todor N. Mazgalev Circ Heart Fail Volume 2(6):692-699 November 1, 2009 Copyright © American Heart Association, Inc. All rights reserved.

Figure 1. Left ventricular end-diastolic and end-systolic volumes and left ventricular ejection fraction at baseline, and at 4- and 8-week ventricular pacing in control and VNS-treated dogs. *P<0.05 versus control group. Figure 1. Left ventricular end-diastolic and end-systolic volumes and left ventricular ejection fraction at baseline, and at 4- and 8-week ventricular pacing in control and VNS-treated dogs. *P<0.05 versus control group. W indicates week; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; VNS, vagus nerve stimulation. Youhua Zhang et al. Circ Heart Fail. 2009;2:692-699 Copyright © American Heart Association, Inc. All rights reserved.

Figure 2. Systolic and diastolic blood pressure levels at baseline, and at 4- and 8-week ventricular pacing in the control and VNS-treated dogs. Figure 2. Systolic and diastolic blood pressure levels at baseline, and at 4- and 8-week ventricular pacing in the control and VNS-treated dogs. W indicates week. SBP, systolic blood pressure; DBP, diastolic blood pressure; VNS, vagus nerve stimulation. Youhua Zhang et al. Circ Heart Fail. 2009;2:692-699 Copyright © American Heart Association, Inc. All rights reserved.

Figure 3. The upper panel shows an example of blood pressure and ECG traces recorded using the DSI telemetric device during baroreflex sensitivity test. Figure 3. The upper panel shows an example of blood pressure and ECG traces recorded using the DSI telemetric device during baroreflex sensitivity test. The lower panel shows the average data at baseline, at 4- and 8-week ventricular pacing in control and VNS-treated dogs. *P<0.05 versus control group. W indicates week; VNS, vagus nerve stimulation. Youhua Zhang et al. Circ Heart Fail. 2009;2:692-699 Copyright © American Heart Association, Inc. All rights reserved.

Figure 4. Plasma C-reactive protein, norepinephrine, and angiotensin II levels at baseline, at 4- and at 8-week ventricular pacing in control and VNS-treated dogs. *P<0.05 versus control group. Figure 4. Plasma C-reactive protein, norepinephrine, and angiotensin II levels at baseline, at 4- and at 8-week ventricular pacing in control and VNS-treated dogs. *P<0.05 versus control group. W indicates week; CRP, C-reactive protein; NE, norepinephrine; ANG II, angiotensin II. Before data analysis, square root transformation was applied for CRP, and logarithmic transformation was used for both NE and ANG II. Youhua Zhang et al. Circ Heart Fail. 2009;2:692-699 Copyright © American Heart Association, Inc. All rights reserved.